NCT00538434 · Interventional trial
Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years
Overall registry status Completed
Phase 2 · Phase 3
Conditions Eosinophilic Esophagitis
Delaware Valley sites
- Children's Hospital of Philadelphia · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory